ストックスクリーナーアプリを入手
773.94
0.84%
-6.56
プレマーケット:
771.00
-2.94
-0.38%
前日終値:
$780.50
開ける：
$776.3
24時間の取引高:
383.17K
Relative Volume:
0.37
時価総額：
$81.34B
収益：
$14.25B
当期純損益:
$4.58B
株価収益率:
18.53
EPS:
41.7701
ネットキャッシュフロー:
$3.88B
1週間 パフォーマンス:
-1.43%
1か月 パフォーマンス:
-0.80%
6か月 パフォーマンス:
+48.55%
1年 パフォーマンス:
+10.16%
1日の値動き範囲:
$770.30
$777.77
1週間の範囲:
$770.30
$792.77
52週間の値動き範囲:
$476.49
$792.77
Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile
名前
Regeneron Pharmaceuticals Inc
セクター
電話
(914) 847-7000
住所
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
REGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
773.94 | 82.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 116.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.25 | 52.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.90 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.09 | 37.61B | 447.02M | -1.18B | -906.14M | -6.1812 |
Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-03 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-24 | 開始されました | HSBC Securities | Buy |
| 2025-11-24 | 再開されました | Truist | Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Perform |
| 2025-08-14 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-06-30 | ダウングレード | Argus | Buy → Hold |
| 2025-05-30 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | アップグレード | Citigroup | Neutral → Buy |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-02-05 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | ダウングレード | UBS | Buy → Neutral |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-09-24 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | 開始されました | Bernstein | Outperform |
| 2024-01-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | 繰り返されました | Oppenheimer | Perform |
| 2023-06-28 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | アップグレード | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | アップグレード | Jefferies | Hold → Buy |
| 2023-03-23 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | アップグレード | Cowen | Market Perform → Outperform |
| 2023-01-20 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-26 | ダウングレード | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-09-09 | アップグレード | Jefferies | Underperform → Hold |
| 2022-09-09 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Neutral |
| 2022-06-06 | 開始されました | Jefferies | Underperform |
| 2022-05-23 | 開始されました | SVB Leerink | Outperform |
| 2022-01-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-01-03 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | 再開されました | Wells Fargo | Overweight |
| 2021-12-07 | 再開されました | Cowen | Market Perform |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 再開されました | BMO Capital Markets | Outperform |
| 2021-11-05 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2021-06-29 | 開始されました | H.C. Wainwright | Buy |
| 2021-01-25 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | アップグレード | The Benchmark Company | Hold → Buy |
| 2021-01-08 | アップグレード | Citigroup | Neutral → Buy |
| 2020-10-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2020-07-09 | アップグレード | SunTrust | Hold → Buy |
| 2020-05-26 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-04-17 | アップグレード | The Benchmark Company | Hold → Buy |
| 2020-04-08 | 開始されました | The Benchmark Company | Hold |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-02-26 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | アップグレード | Jefferies | Hold → Buy |
| 2020-02-11 | アップグレード | Argus | Hold → Buy |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-16 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-12-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | 開始されました | SunTrust | Hold |
| 2019-11-07 | アップグレード | Citigroup | Neutral → Buy |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-09-23 | アップグレード | Guggenheim | Neutral → Buy |
すべてを表示
Regeneron Pharmaceuticals Inc (REGN) 最新ニュース
Generate Investment Management Ltd Acquires 6,778 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Simplify Asset Management Inc. Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Rockland IDA votes to terminate and recapture Regeneron incentives - Westfair Communications
J&J Bispecific For Atopic Dermatitis Fails To Pass Muster - Citeline News & Insights
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
TB Alternative Assets Ltd. Increases Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Bellecapital International Ltd. Buys 2,276 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Earnings Notes - Trefis
Cwm LLC Has $30.03 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Beacon Investment Advisory Services Inc. - MarketBeat
Morgan Stanley Sees Policy Risks Receding for Regeneron (REGN) - Insider Monkey
Vontobel Holding Ltd. Has $5.83 Million Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Will Regeneron Pharmaceuticals Inc. stock split attract more investorsMarket Sentiment Shifts & High Return Capital Gain - bollywoodhelpline.com
Exchange Traded Concepts LLC Purchases 1,369 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron (REGN): Revisiting Valuation After Japan’s Dupixent Pediatric Asthma Approval and Bullish Investor Positioning - simplywall.st
Regeneron Pharmaceuticals, Inc. $REGN Stake Lifted by Hunter Perkins Capital Management LLC - MarketBeat
Swedbank AB Cuts Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Bar Harbor Wealth Management Purchases 3,304 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
ARS Investment Partners LLC Increases Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Brighton Jones LLC Buys 2,335 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
10 Best Debt Free Dividend Stocks to Buy Now - Insider Monkey
Does Regeneron Still Offer Value After Strong Five Year Share Price Gains? - Yahoo Finance
Sanofi Eczema Drug Linked To Lymphoma, Suit Says - Law360
Regeneron Pharmaceuticals's Options Frenzy: What You Need to Know - Benzinga
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 1-Year HighHere's What Happened - MarketBeat
Regeneron stock reaches 52-week high at $791.00 By Investing.com - Investing.com Australia
Regeneron stock reaches 52-week high at $791.00 - Investing.com
Regeneron Pharmaceuticals Stock (REGN) Opinions on Dupixent Success and Pipeline Developments - Quiver Quantitative
Sanofi, Regeneron’s Dupixent approved in Japan for children with asthma (SNY:NASDAQ) - Seeking Alpha
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma - The Manila Times
Regeneron and Sanofi Announce Approval of Dupixent® for Asthma Treatment in Children Aged 6 to 11 in Japan - Quiver Quantitative
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Diabetic Retinopathy Market to See Booming Growth 2025-2032 | - openPR.com
Aug Final Week: Will Regeneron Pharmaceuticals Inc. stock benefit from M&A activityJuly 2025 Snapshot & Safe Swing Trade Setups - moha.gov.vn
Wedge Capital Management L L P NC Buys New Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Stock Holdings Lifted by Osaic Holdings Inc. - MarketBeat
Regeneron: The Turnaround Is Gaining Steam - Seeking Alpha
Published on: 2025-12-20 18:02:12 - Улправда
Voya Investment Management LLC Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Corient Private Wealth LLC - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Should Regeneron’s Clarified Eylea Biosimilar Timeline Reshape How REGN Investors View Its Core Franchise? - simplywall.st
Alvotech and Teva Settle With Regeneron on U.S. Launch Timing for Eylea Biosimilar AVT06 - TipRanks
Published on: 2025-12-19 17:35:07 - Улправда
How interest rate cuts could boost Regeneron Pharmaceuticals Inc. stockSwing Trade & Daily Technical Forecast Reports - DonanımHaber
Goldman Sachs Adjusts PT on Regeneron Pharmaceuticals to $807 From $788, Maintains Buy Rating - marketscreener.com
Texas Permanent School Fund Corp Cuts Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S. (TEVA:NYSE) - Seeking Alpha
Alvotech and Teva Pharmaceuticals Announce Settlement Agreement with Regeneron for AVT06 Biosimilar Launch in the U.S. - Quiver Quantitative
Regeneron Pharmaceuticals Inc (REGN) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.05%
大文字化:
|
ボリューム (24 時間):